| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SAN DIEGO—Researchers at the University of California San Diego School of Medicine have developed the first mice that lack the Upf3b gene, providing a new model for studying its underlying role in intellectual disabilities and neurodevelopmental disorders. The study was published Sept. 26 in Molecular Psychiatry.
 
In humans, mutations in the UPF3B gene cause intellectual disabilities and are strongly associated with autism spectrum disorder, attention deficit hyperactivity disorder and schizophrenia. This gene plays a role in nonsense-mediated RNA decay (NMD), a supervisory system cells use as “volume control” on many genes.
 
“These observations about UPF3B made us wonder if NMD is important for mammalian brain development,” said senior author Dr. Miles Wilkinson, a professor of reproductive medicine at the university’s medical school.
 
NMD acts on messenger RNAs (mRNAs) and was initially thought to serve only as a quality control mechanism in that it degraded irregular mRNAs that encode potentially harmful proteins. But it has more recently become clear, the university notes, that NMD also degrades normal mRNAs in specific cell types and situations when they are not needed.
 
Wilkinson’s team found that Upf3b-deficient mice differed from normal mice in a number of cellular and behavioral ways. For example, their neural stem cells were impaired in their ability to specialize into functional neurons. The neurons they did have were deficient in their ability to form dendrites and dendritic spines, structures critical for neuron-neuron communication. These Upf3b-deficient mice also exhibited defects in a specific form of memory and learning related to fear, and they were defective in sensory processing in a way often associated with schizophrenia and other brain disorders.

Related Topics

Published In

Volume 13 - Issue 12 | December 2017

December 2017

December 2017 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
A group of blue capsules is scattered on a bright yellow surface, with one capsule opened to reveal white powder inside.

Understanding drug impurities: types, sources, and analytical strategies

Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue